About Uveitis YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg

About Uveitis

Uveitis is inflammation of the part of the eye called the uvea

Uveitis (pronounced YOU-Vee-Eye-Tis) is a word that refers to inflammation of the part of the eye called the uvea (YOU-Vee-Ah). In posterior segment uveitis, the inflammation is in the back of the eye and may affect the retina, choroid (middle wall of the eye), and/or optic nerve. Posterior segment uveitis is one of the least common forms of uveitis but is the form most associated with vision loss.

If you or a loved one has been diagnosed with posterior uveitis, understanding the condition is an important first step in managing symptoms. Uveitis (pronounced YOU-Vee-Eye-Tis) is a general term that refers to inflammation of the part of the eye called the uvea (YOU-Vee-Ah).

Uveitis causes

There are 2 types of uveitis—infectious and non-infectious. In some cases, the uveitis causes are unknown.

Infectious causes:

Bacterial infection
Fungal infection
Parasitic infection
Viral infection

Non-infectious causes:

Autoimmune disorders
Allergies
Malignancies (tumors)
Trauma

Understanding the cause of posterior segment uveitis will help your eye doctor choose the right treatment. You should tell your eye doctor any uveitis symptoms you are experiencing. Find more information about common uveitis symptoms.

See common uveitis symptoms

Get answers to FAQs

*People pictured are not real patients unless otherwise noted.

INDICATION AND USAGE

YUTIQ^® (fluocinolone acetonide intravitreal implant) 0.18 mg contains a corticosteroid and is for the treatment of patients with chronic, non-infectious uveitis affecting the back of the eye.

IMPORTANT SAFETY INFORMATION

Do not take YUTIQ if:

You have, or suspect you have, an eye infection
If you have been told you are allergic to any of the ingredients in YUTIQ

YUTIQ may cause serious side effects, including:

Injection-related effects, steroid-related effects and movement of the implant.

Call your doctor if your eye becomes red, sensitive to light, painful or if your vision changes or becomes blurred.

You may experience temporary blurred vision. Do not drive or use machines until your vision clears.

The most common side effects in the eye were cataract and reduced clarity of vision. The most common side effects not related to the eye were upper respiratory infection, high blood pressure and joint pain.

If you are pregnant, become pregnant or consider breastfeeding after having received YUTIQ inform your doctor immediately.

Please see full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.

YUTIQ, the YUTIQ logo, and the EyePoint logo are registered trademarks of EyePoint Pharmaceuticals, Inc. EyePoint Assist is a service mark of EyePoint Pharmaceuticals, Inc.

480 Pleasant Street, Suite B300, Watertown, MA 02472

12/2022

US-YUT-2200116

INDICATION AND USAGE

YUTIQ^® (fluocinolone acetonide intravitreal implant) 0.18 mg contains a corticosteroid and is for the treatment of patients with chronic, non-infectious uveitis affecting the back of the eye.

IMPORTANT SAFETY INFORMATION

Do not take YUTIQ if:

You have, or suspect you have, an eye infection
If you have been told you are allergic to any of the ingredients in YUTIQ